Oxidative imbalance in child and adolescent patients with attention-deficit/hyperactivity disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 8, 2010, Pages 1491-1494

  Ceylan, Mehmet ^a   Sener, Sahnur ^b   Bayraktar, Aslihan Cavunt ^b   Kavutcu, Mustafa ^b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Antioxidant enzymes; Attention deficit hyperactivity disorder; Malondialdehyde; Nitric oxide; Oxidative stress

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; SCHOOL CHILD; VENOUS BLOOD;

ADOLESCENT; AGE FACTORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIOLOGICAL MARKERS; CATALASE; CHILD; FEMALE; HUMANS; MALE; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; UP-REGULATION;

EID: 78649523256     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.08.010     Document Type: Article

References (46)

1. Aebi H. Catalase. Methods of enzymatic analysis 1974, 673-677. Academic Press, New York and London. H.U. Bergmeyer (Ed.).
2. Akyol O., Herken H., Uz E., Fadillioglu E., Unal S., Sogut S., et al. The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26:995-1005.
3. Akyol O., Zoroglu S.S., Armutcu F., Sahin S., Gurel A. Nitric oxide as a physiopathological factor in neuropsychiatric disorders. In Vivo 2004, 18:377-390.
4. American Psychiatric Association Diagnostic and statistical manual of mental disorders, 4th, Text-Revision (DSM-IV-TR) 2000, American Psychiatric Association, Washington (DC).
5. Andreazza A.C., Frey B.N., Erdtmann B., Salvador M., Rombaldi F., Santin A., et al. DNA damage in bipolar disorder. Psychiatry Res 2007, 153(1):27-32.
6. Aspide R., Fresiello A., de Filippis G., Gironi Carnevale U.A., Sadile A.G. Non-selective attention in a rat model of hyperactivity and attention deficit: subchronic methylphenydate and nitric oxide synthesis inhibitor treatment. Neurosci Biobehav Rev 2000, 24(1):59-71.
7. Bilici M., Efe H., Köroǧlu M.A., Uydu H.A., Bekaroǧlu M., Deǧer O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 2001, 64(1):43-51.
8. Brookes K.J., Chen W., Xu X., Taylor E., Asherson P. Association of fatty acid desaturase genes with attention-deficit/hyperactivity disorder. Biol Psychiatry 2006, 60:1053-1061.
9. Bulut M., Selek S., Gergerlioglu H.S., Savas H.A., Yilmaz H.R., Yuce M., et al. Malondialdehyde levels in adult attention-deficit hyperactivity disorder. J Psychiatry Neurosci 2007, 32(6):435-438.
10. de Krom M., Staal W.G., Ophoff R.A., Hendriks J., Buitelaar J., Franke B., et al. A common variant in DRD3 receptor is associated with autism spectrum disorder. Biol Psychiatry 2009, 65:625-630.
11. Delion S., Chalon S., Hérault J., Guilloteau D., Besnard J.C., Durand G. Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J Nutr 1994, 124(12):2466-2476.
12. Durak I., Canbolat O., Kavutcu M., Öztürk H.S., Yurtarslani Z. Activities of total, cytoplasmic and mitochondrial superoxide dismutase enzymes in sera and pleural fluids from patient with lung cancer. J Clin Lab Anal 1996, 10:17-20.
13. Durak I., Kavutcu M., Kaçmaz M., Avci A., Horasanli E., Dikmen B., et al. Effects of isoflurane on nitric oxide metabolism and oxidant status of guinea pig myocardium. Acta Anaesthesiol Scand 2001, 45(1):119-122.
14. Fridovich I. Superoxide dismutases: regularities and irregularities. Harvey Lect 1983-84, 79:51-75.
15. Gadow K.D., Roohi J., DeVincent C.J., Hatchwell E. Association of ADHD, tics, and anxiety with dopamine transporter (DAT1) genotype in autism spectrum disorders. J Child Psychol Psychiatry 2008, 49:1331-1338.
16. Geier D.A., Mumper E., Gladfelter B., Coleman L., Geier M.R. Neurodevelopmental disorders, maternal Rh-negativity, and Rho(D) immune globulins: a multi-center assessment. Neuro Endocrinol Lett 2008, 29(2):272-280.
17. Guemouri L., Artur Y., Herbeth B., Jeandel C., Cuny G., Siest G. Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood. Clin Chem 1991, 37(11):1932-1937.
18. Halliwell B., Gutteridge J.M. The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990, 280(1):1-8.
19. Herken H., Gurel A., Selek S., Armutcu F., Ozen M.E., Bulut M., et al. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res 2007, 38(2):247-252.
20. Joshi K., Lad S., Kale M., Patwardhan B., Mahadik S.P., Patni B., et al. Supplementation with flax oil and vitamin C improves the outcome of Attention Deficit Hyperactivity Disorder (ADHD). Prostaglandins Leukot Essent Fatty Acids 2006, 74(1):17-21.
21. Kaufman J., Birmaher B., Brent D., Rao U., Flynn C., Moreci P., et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997, 36(7):980-988.
22. Kern J.K., Jones A.M. Evidence of toxicity, oxidative stress, and neuronal insult in autism. J Toxicol Environ Health B Crit Rev 2006, 9(6):485-499.
23. Kuloglu M., Ustundag B., Atmaca M., Canatan H., Tezcan A.E., Cinkilinc N. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct 2002, 20(2):171-175.
24. Levy F. The dopamine theory of attention deficit hyperactivity disorder (ADHD). Aust N Z J Psychiatry 1991, 25(2):277-283.
25. Mahadik S.P., Mukherjee S. Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophr Res 1996, 19(1):1-17.
26. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43(2):109-142.
27. Montgomery K.S., Mackey J., Thuett K., Ginestra S., Bizon J.L., Abbott L.C. Chronic, low-dose prenatal exposure to methylmercury impairs motor and mnemonic function in adult C57/B6 mice. Behav Brain Res 2008, 191(1):55-61.
28. Ng F., Berk M., Dean O., Bush A.I. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 2008, 11(6):851-876.
29. Nunez E.A. Preface-fatty acids and cell signalling. Prostaglandins Leukot Essent Fatty Acids 1993, 48(1):1-4.
30. Nunomura A., Moreira P.I., Takeda A., Smith M.A., Perry G. Oxidative RNA damage and neurodegeneration. Curr Med Chem 2007, 14(28):2968-2975.
31. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70:158-169.
32. Rommelse N.N., Franke B., Geurts H.M., Hartman C.A., Buitelaar J.K. Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. Eur Child Adolesc Psychiatry 2010, 19(3):281-295.
33. Savas H.A., Gergerlioglu H.S., Armutcu F., Herken H., Yilmaz H.R., Kocoglu E., et al. Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World J Biol Psychiatry 2006, 7(1):51-55.
34. Scahill L., Schwab-Stone M. Epidemiology of ADHD in school-age children. Child Adolesc Psychiatr Clin N Am 2000, 9(3):541-555.
35. Selek S., Herken H., Bulut M., Ceylan M.F., Celik H., Savas H.A., et al. Oxidative imbalance in obsessive compulsive disorder patients: a total evaluation of oxidant-antioxidant status. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32(2):487-491.
36. Selek S., Savas H.A., Gergerlioglu H.S., Bulut M., Yilmaz H.R. Oxidative imbalance in adult attention deficit/hyperactivity disorder. Biol Psychol 2008, 79(2):256-259.
37. Söǧüt S., Zoroǧlu S.S., Ozyurt H., Yilmaz H.R., Ozuǧurlu F., Sivasli E., et al. Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin Chim Acta 2003, 331(1-2):111-117.
38. Spahis S., Vanasse M., Bélanger S.A., Ghadirian P., Grenier E., Levy E. Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 2008, 79(1-2):47-53.
39. Tripp G., Wickens J.R. Neurobiology of ADHD. Neuropharmacology 2009, 57(7-8):579-589.
40. Van Ye T.M., Roza A.M., Pieper G.M., Henderson J., Johnson J.P., Adams M.B. Inhibition of intestinal lipid peroxidation does not minimize morphological damage. J Surg Res 1993, 55:553-558.
41. Varol Tas F., Guvenir T., Tas G., Cakaloz B., Ormen M. Nitric oxide levels in disruptive behavioral disorder. Neuropsychobiology 2006, 53:176-180.
42. Wasowics W., Neve S., Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 1993, 39:2522-2526.
43. Wechsler D. WISC-R, manual for the Wechsler Intelligence Scale for Children-Revised 1974, Psychological Corporation, New York (US).
44. Young H.A., Geier D.A., Geier M.R. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink. J Neurol Sci 2008, 271(1-2):110-118.
45. Yumru M., Savas H.A., Kalenderoglu A., Bulut M., Celik H., Erel O. Oxidative imbalance in bipolar disorder subtypes: a comparative study. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33(6):1070-1074.
46. Zoroglu S.S., Yürekli M., Meram I., Söǧüt S., Tutkun H., Yetkin O., et al. Pathophysiological role of nitric oxide and adrenomedullin in autism. Cell Biochem Funct 2003, 21(1):55-60.